Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by willibrichon Dec 06, 2010 2:45pm

539 Views

Post# 17807389

Could be good news coming

I see that our partners BWN have traded just under 2.6 million shares this morning. After seeing them open @ .78 and then shoot up to 1.01 all of a sudden ( now trading @ .92 at 11.41 a.m. ) on such large volume, I can only guess that the folks holding a massive short position in BWN ...................something like 6 million shares..............decided to bite the bullet after waiting to see if they could pick up some cheaper BWN shares during tax loss selling season.

So we could be in for good news very soon

Ho Ho Ho MERRY CHRI$MA$.

Bullboard Posts

Canopy Growth nears adjusted EBITDA profitability in Q2 2025